1967
DOI: 10.1001/archderm.1967.01610010095017
|View full text |Cite
|
Sign up to set email alerts
|

Some in Vitro Effects of Hypoglycin on Skin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1973
1973
1991
1991

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 2 publications
0
3
0
Order By: Relevance
“…It is first deaminated by trans- of methylenecyclopropylacetate (MCPA) rise to a maximum by 4-5 hr and then slowly decline. It is not known what proportion of hypoglycin degradation normally occurs in the liver -skin for example appears to be able to metabolise it [29] and extrahepatic tissues are a major site of branced chair amino acid catabolism. Whether MCPA can be degraded further has not been shown.…”
Section: Degradationmentioning
confidence: 99%
See 1 more Smart Citation
“…It is first deaminated by trans- of methylenecyclopropylacetate (MCPA) rise to a maximum by 4-5 hr and then slowly decline. It is not known what proportion of hypoglycin degradation normally occurs in the liver -skin for example appears to be able to metabolise it [29] and extrahepatic tissues are a major site of branced chair amino acid catabolism. Whether MCPA can be degraded further has not been shown.…”
Section: Degradationmentioning
confidence: 99%
“…Similar results have not been published for MCPA. Sherratt [29,34,35] has questioned the validity of this 'sequestration' hypothesis since a number of nonhypoglycaemic compounds can also affect intramitochondrial CoA concentrations.…”
Section: Metabolic Actionsmentioning
confidence: 99%
“…The pharmacological effects of hypoglycin, namely hypoglycaemia [3], hyperketonaemia [11] and a pronounced organic aciduria [16,17], are the results of these inhibitions [8,18]. By analogy with hypoglycin, it has been suggested that MCPG is converted into a toxic metabolite, methylenecyclopropylformyl-CoA (MCPF-CoA) (Scheme 1) [2,19]. Metabolites of MCPG inhibit ,-oxidation, but at a different stage from those of hypoglycin [2].…”
Section: Introductionmentioning
confidence: 99%